Press release
Hemorrhoids Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Citius Pharma, Nivagen Pharma, Edesa Biotech
The Hemorrhoids Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
"Hemorrhoids Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Hemorrhoids Market.
Some of the key takeaways from the Hemorrhoids Pipeline Report: https://www.delveinsight.com/sample-request/hemorrhoids-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Hemorrhoids treatment therapies with a considerable amount of success over the years. Hemorrhoids Key players such as - Edesa Biotech, Citius Pharmaceuticals, Nivagen Pharmaceuticals Inc., and others, are developing therapies for the Hemorrhoids treatment
• Hemorrhoids Emerging therapies such as - EB02, Halo-Lido, Hydrocortisone Acetate Suppository, and others are expected to have a significant impact on the Hemorrhoids market in the coming years.
• In June 2023, Citius Pharmaceuticals applied for patents for the formulations of Halo-Lido (CITI-002) hemorrhoid cream following an assessment of the Phase IIb trial outcomes.
Hemorrhoids Overview
Hemorrhoids, also known as piles, are swollen and inflamed veins in the rectm that cause discomfort, itching, pain, and bleeding. They can be internal (inside the rectm) or external (under the skin around the anus). Common causes include straining during bowel movements, chronic constipation, pregnancy, obesity, and prolonged sitting. Hemorrhoids are a common condition and are usually treated with lifestyle changes, topical treatments, or minimally invasive procedures. In severe cases, surgical removal may be necessary. Maintaining a high-fiber diet, staying hydrated, and practicing good bowel habits help prevent and manage hemorrhoids.
Get a Free Sample PDF Report to know more about Hemorrhoids Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/hemorrhoids-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Route of Administration
Hemorrhoids pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical
• Molecule Type
Molecule Type
Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type
Hemorrhoids Pipeline Therapeutics Assessment
• Hemorrhoids Assessment by Product Type
• Hemorrhoids By Stage and Product Type
• Hemorrhoids Assessment by Route of Administration
• Hemorrhoids By Stage and Route of Administration
• Hemorrhoids Assessment by Molecule Type
• Hemorrhoids by Stage and Molecule Type
DelveInsight's Hemorrhoids Report covers around 3+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Some of the key companies in the Hemorrhoids Therapeutics Market include:
Key companies developing therapies for Hemorrhoids are - Johnson & Johnson, Boston Scientific Corporation, Medtronic plc, CONMED Corporation, Cook Medical, Sklar Surgical Instruments, Integra LifeSciences Corporation, Surkon Medical Co., Ltd., and Medline Industries, Inc., and others.
Emerging Hemorrhoids Drugs Under Different Phases of Clinical Development Include:
• EB02: Edesa Biotech
• Halo-Lido: Citius Pharmaceuticals
• Hydrocortisone Acetate Suppository: Nivagen Pharmaceuticals Inc.
Download Sample PDF Report to know more about Hemorrhoids drugs and therapies
https://www.delveinsight.com/sample-request/hemorrhoids-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Hemorrhoids Pipeline Analysis:
The Hemorrhoids pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Hemorrhoids with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Hemorrhoids Treatment.
• Hemorrhoids key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Hemorrhoids Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Hemorrhoids market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Hemorrhoids product details are provided in the report. Download the Hemorrhoids pipeline report to learn more about the emerging Hemorrhoids therapies
https://www.delveinsight.com/sample-request/hemorrhoids-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Hemorrhoids Pipeline Market Drivers
• Rise in awareness about hemorrhoids
• Increase in reported cases of hemorrhoids
Hemorrhoids Pipeline Market Barriers
• Lack of specialized personnel and healthcare infrastructure for the treatment of hemorrhoids
• The time taking treatment procedure is also a hindrance to the growth of the hemorrhoids treatment market
Scope of Hemorrhoids Pipeline Drug Insight
• Coverage: Global
• Key Hemorrhoids Companies: Edesa Biotech, Citius Pharmaceuticals, Nivagen Pharmaceuticals Inc., and others
• Key Hemorrhoids Therapies: EB02, Halo-Lido, Hydrocortisone Acetate Suppository, and others
• Hemorrhoids Therapeutic Assessment: Hemorrhoids current marketed and Hemorrhoids emerging therapies
• Hemorrhoids Market Dynamics: Hemorrhoids market drivers and Hemorrhoids market barriers
Request for Sample PDF Report for Hemorrhoids Pipeline Assessment and clinical trials
https://www.delveinsight.com/sample-request/hemorrhoids-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Hemorrhoids Report Introduction
2 Hemorrhoids Executive Summary
3 Hemorrhoids Overview
4 Hemorrhoids- Analytical Perspective In-depth Commercial Assessment
5 Hemorrhoids Pipeline Therapeutics
6 Hemorrhoids Late Stage Products (Phase II/III)
7 Hemorrhoids Mid Stage Products (Phase II)
8 Hemorrhoids Early Stage Products (Phase I)
9 Hemorrhoids Preclinical Stage Products
10 Hemorrhoids Therapeutics Assessment
11 Hemorrhoids Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Hemorrhoids Key Companies
14 Hemorrhoids Key Products
15 Hemorrhoids Unmet Needs
16 Hemorrhoids Market Drivers and Barriers
17 Hemorrhoids Future Perspectives and Conclusion
18 Hemorrhoids Analyst Views
19 Appendix
20 About DelveInsight
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Related Reports:
Hemorrhoids Market https://www.delveinsight.com/report-store/hemorrhoids-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Hemorrhoids-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Hemorrhoids Epidemiology https://www.delveinsight.com/report-store/hemorrhoids-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Hemorrhoids Epidemiology Forecast to 2034' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
• Sinusitis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-market
• Pd-1 & Pdl1 Market: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
• Cervical Dysplasia Market: https://www.delveinsight.com/report-store/cervical-dysplasia-market-insights
• Hypogonadism Market: https://www.delveinsight.com/report-store/hypogonadism-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Non-hodgkin's Lymphoma Market: https://www.delveinsight.com/report-store/non-hodgkins-lymphoma-market
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hemorrhoids Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Citius Pharma, Nivagen Pharma, Edesa Biotech here
News-ID: 4091781 • Views: …
More Releases from DelveInsight Business Research
Global Intranasal Drug Delivery Market to reach USD 104,248.63 million by 2032 a …
According to DelveInsight's analysis, The Intranasal Drug Delivery market expansion is largely fueled by the growing burden of chronic conditions such as neurological, respiratory, severe allergic, and eye-related disorders. The rising preference for fast-acting, non-invasive drug delivery solutions is also boosting the market, as intranasal administration provides quick absorption and user-friendly dosing, improving both adherence and treatment outcomes. Additionally, increased research efforts and a wave of new product introductions from…
Global Clinical Trial Support Services Market to reach USD 43,160.56 million by …
According to DelveInsight's analysis, The clinical trial support services market is expanding swiftly, largely driven by the increasing incidence of chronic illnesses such as diabetes, cancer, and cardiovascular diseases. This rise has resulted in a higher volume of clinical trials, greater R&D spending, and stronger investment in new drug development. Moreover, the growing collaboration among pharmaceutical, biotechnology, and medical device companies is boosting the need for specialized services, including regulatory…
Global Respiratory Inhalers Market to reach USD 51,132.25 million by 2032 at a C …
According to DelveInsight's analysis, The demand for respiratory inhalers is rising sharply, driven by a combination of factors. Chief among these is the increasing prevalence of respiratory disorders, including asthma, COPD, bronchitis, and bronchospasm, which continue to impact a growing global population and create a need for fast and effective treatments. Simultaneously, patient awareness regarding early diagnosis and consistent management of asthma and COPD is improving, further supporting market growth.…
Global Dysmenorrhea Treatment Market to reach USD 7,909.14 million by 2032 at a …
According to DelveInsight's analysis, The widespread occurrence of dysmenorrhea (menstrual pain), along with rising awareness and better diagnostic practices, is driving strong growth in the dysmenorrhea treatment market. As more women seek professional care for menstrual pain, the need for effective therapies from OTC painkillers to hormonal treatments continues to increase. Awareness initiatives and educational programs are also reducing stigma and promoting earlier treatment-seeking behavior. Meanwhile, leading companies are advancing…
More Releases for Hemorrhoids
Hemorrhoids Market Projected to Reach USD 3.7 Billion by 2034
Hemorrhoids, also known as piles, are swollen and inflamed veins in the anus that cause discomfort, bleeding, pain, and itching. They are one of the most common anorectal conditions, affecting millions of people worldwide across all age groups. Risk factors include sedentary lifestyle, obesity, chronic constipation, pregnancy, and aging populations.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71143
Although often underreported due to stigma, the rising prevalence of hemorrhoids is…
Hemorrhoids Market Size, Share, Trends & Forecast To 2034
Market Overview:
The hemorrhoids market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market's performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical…
Mexico Hemorrhoids Treatment Market Size, Share, Industry, Forecast to 2029
The Mexico Hemorrhoids Treatment Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Mexico Hemorrhoids Treatment market. This report explores all the key factors affecting the growth of the global Mexico Hemorrhoids…
Hemorrhoids Treatment Device Market Applications, Key Players, Regions 2017-2027
Hemorrhoids are is a common condition that mainly develops at the base of the anal region. This condition employs various treatment methods that make use of specific devices
The principle of ligation with rubber bands is to encircle the base of the hemorrhoidal clump with a tight rubber band. The tissue cut off by the rubber band dies, and is replaced by an ulcer that heals with scarring.
Rubber band ligation can…
Hemorrhoids Clinical Trials Review 2016 By Global Market Research Store
“Hemorrhoids Global 2016 Clinical Trials Review, H2" provides an detailed overview of Hemorrhoids scenario.
Report includes top line data relating on Hemorrhoids Global clinical trials scenario.
This report on Hemorrhoids also includes an review of trial numbers as well as their ( Hemorrhoids ) average enrollment in uppermost/top countries which are conducted worldwide.
Hemorrhoids report also covers disease clinical trials by country (G7 & E7), sponsor type, region, trial status…
A secret problem – Taboo hemorrhoids
Often it starts with a burning sensation on the skin. This is not only painful but also embarrassing, because it appears in a very intimate place, namely in the rectum. Many people have inhibitions to talk about problems with hemorrhoids. Hemorrhoids itself are really only arteriovenous vascular pads at the end of the rectum and are necessary for safe closure of the anus. If the veins will dilate and bulge…
